Tag
Jubilant Pharmova Limited
3 articles
Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance
Jubilant Pharmova's board approved issuance of up to ₹800 crore in listed NCDs via private placement in one or more tranches.
The company will seek shareholder approval via postal ballot for raising u
Jubilant Pharmova Invests CAD 94.5M to Double RUBY-FILL® Capacity
Jubilant Pharmova's subsidiary announces a CAD 94.5 million investment to modernize and double production capacity for its flagship radiopharmaceutical product, RUBY-FILL®.
The Government of Canada wi
Jubilant Pharmova Board to Consider Fundraising via NCDs
Jubilant Pharmova's board will meet on October 12, 2026, to consider fundraising via Non-Convertible Debentures.
The board will seek necessary shareholder approvals for the proposed issuance of NCDs o